Navigation Links
DrugRisk Update: Evidence Submitted in Actos Lawsuit Suggests Drug Maker Knew of Cancer Risks
Date:3/19/2013

New York, NY (PRWEB) March 19, 2013

The prescription drug resource center DrugRisk.com is alerting patients who have taken the drug Actos of updated legal news on the site. The resource site learned this week of new evidence showing the manufacturer may have known of the risks of bladder cancer in 2003, but did nothing to warn patients.

“The goal of DrugRisk is to improve consumer safety by publishing the latest drug warnings, recalls, studies and litigation news. Informed patients can discuss options with their doctor and decide if they need legal advice,” explains DrugRisk representative Ryan Mayer.

The resource center contains Actos warnings from both the FDA* and European Medicines Agency** who indicated that long-term use of the drug may be associated with an increased risk of bladder cancer. The drug has also been banned in France and Germany.***

In legal news, Takeda, the maker of Actos faces as many as 3,000 claims over Actos bladder cancer.**** More than 1,200 patients have filed an Actos lawsuit against the drug maker in a special multi-district federal court in Louisiana.***** Other cases have been filed in California.****

The first Actos trial began this month in California. Now, DrugRisk has learned that lawyers representing a man dying of cancer in that trial filed a study on January 25th which shows Takeda asked doctors in 2003 if they would still prescribe a diabetes drug that had bladder cancer risks. However, they didn’t disclose their concerns to patients.****

Lawyers are still helping those affected file claims. Anyone diagnosed with bladder cancer after taking Actos is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of defective drug injury cases, DrugRisk only recommends lawyers and law firms who have already handled Actos lawsuits.

For more information on the research, side effects, litigation news and a potential Actos recall or to speak with a lawyer, visit http://www.DrugRisk.com.

*fda.gov/ForConsumers/ConsumerUpdates/ucm263431.htm#Actos
**http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/07/news_detail_001311.jsp&mid=WC0b01ac058004d5c1
***cbsnews.com/8301-504763_162-20070492-10391704.html
****businessweek.com/news/2013-02-15/takeda-worried-about-actos-s-cancer-link-filing-shows
***** In Re: Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana (Lafayette).

Read the full story at http://www.prweb.com/releases/actos-recall/actos-lawsuits/prweb10491110.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Update: Bayer Discloses $500 Million Remaining for Yaz Lawsuits
2. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
3. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
4. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
5. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
6. DrugRisk Announces New Pradaxa Health Warning From Australia
7. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
8. DrugRisk Announces Updated Information on Mirena Lawsuits
9. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
10. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
11. Update: Number of Stryker Rejuvenate Hip Recall Lawsuits Growing in New Jersey Multicounty Litigation, Announces Wright & Schulte LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... 03, 2016 , ... Penrose Senior Care Auditors® was announced ... evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony and Banquet ... for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ingenuity, commitment ...
(Date:12/4/2016)... , ... December 04, 2016 , ... ... major cosmetic surgery can now take advantage of a cosmetic procedure known as ... rejuvenation treatment that reduces the appearance of age spots, fine lines, uneven ...
(Date:12/4/2016)... PITTSBURGH, PA (PRWEB) , ... December 04, 2016 , ... ... not enough. One must brush properly to achieve optimal results. This important necessity inspired ... saw a need for a way to ensure that people break or avoid bad ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in ... Conference Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New ... Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and ...
(Date:12/2/2016)... DIEGO, Calif. (PRWEB) , ... December 02, 2016 , ... ... Event at the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals ... myeloproliferative neoplasms (MPNs) by going above and beyond the standard of care, demonstrating leadership ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Health and Gateway Health proudly announce a dynamic collaboration that ... plan members with specific high risk needs. In ... group of consumers, Wellbridge combines technology and population expertise with ... members, daily behaviors and lifestyle. ... , , ...
(Date:12/5/2016)...  New research by the CVS Health (NYSE: ... U.S. Department of Health and Human Services, Office ... (ASPR), published online today in JAMA Internal ... patients with chronic conditions to refill medications prior ... affirms that public-private partnerships can facilitate timely pharmacy ...
(Date:12/5/2016)... 5, 2016  BD (Becton, Dickinson and Company) (NYSE: ... company, will demonstrate an enhanced technology platform designed with ... the company,s leading Pyxis™ and Alaris™ systems, at this ... Midyear Meeting being held in Las ... national data show that approximately 68 percent of medication ...
Breaking Medicine Technology: